Hubei Goto Biopharm Co., Ltd. (300966)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
26. 69
-0.05
-0.187%
¥
2.49B Market Cap
- P/E Ratio
0.02% Div Yield
2.3M Volume
- Eps
¥ 26.74
Previous Close Want to track 300966 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300966 closed today lower at ¥26.69, a decrease of -0.187% from yesterday's close, completing a monthly decrease of -3.2971% or -¥0.91. Over the past 12 months, 300966 stock gained 34.798%.
300966 pays dividends to its shareholders, with the most recent payment made on Jul 16, 2026. The next estimated payment will be in 3 weeks ago on Jul 16, 2026 for a total of ¥0.045.
The stock of the company had never split.
The company's stock is traded on one exchange.
300966 Chart
People also search for
Hubei Goto Biopharm Co., Ltd. (300966) FAQ
What is the stock price today?
The current price is ¥26.69.
On which exchange is it traded?
Hubei Goto Biopharm Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300966.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.02%.
What is its market cap?
As of today, the market cap is 2.49B.
Has Hubei Goto Biopharm Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Hubei Goto Biopharm Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Zubin Xi CEO | XSHE Exchange | CNE100004K94 ISIN |
| CN Country | 817 Employees | 16 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Overview
Hubei Goto Biopharm Co., Ltd., founded in 2006 and headquartered in Xiangyang, China, stands as a notable entity in the biopharmaceutical industry, dedicated to the research, development, manufacturing, and international and domestic sales of steroid drug raw materials and intermediates. Its services and products are crucial for the pharmaceutical sector, catering to a variety of medical needs across the globe.
Products and Services
Hubei Goto Biopharm Co.,Ltd. offers a comprehensive range of products that encompass starting materials, intermediates, and various pharmaceutical raw materials. Specifically, their offerings include:
- Androstenedione: A precursor in the biochemical synthesis of androgens and estrogens, instrumental in the production of medications related to sex hormone regulation and replacement therapies.
- Bisnordiol: Utilized in the synthesis of semisynthetic and synthetic steroids, this starting material plays a pivotal role in developing new pharmaceutical compounds.
- 9-Hydroxyandrostenedione: Important in the creation of steroidal drugs, this compound serves as a critical intermediary in various biochemical synthesis processes.
- Sex Hormone Intermediates: These intermediates are essential in the production of drugs that target hormonal imbalances, providing critical components for medications used in hormone replacement therapy and other treatments.
- Progesterone Intermediates: Vital for producing progestin and other progesterone-based medications, these intermediates support therapies for a range of conditions, including menstrual disorders and menopausal symptoms.
- Corticosteroid Intermediates: These intermediates are key ingredients in manufacturing corticosteroid drugs, which are used to treat a variety of conditions including allergies, asthma, and autoimmune diseases.
- Other Pharmaceutical Raw Materials: Hubei Goto Biopharm Co.,Ltd. also provides an array of additional raw materials that serve as the foundation for numerous other pharmaceutical products, demonstrating their wide-ranging expertise in the field.
Contact Information
Address: 5th Floor, Building A, Servo Industrial Park, Xiangyang, China, 441000
Phone: 86 71 0342 3122
Website: https://www.gotopharm.com/
